United States · FDA National Drug Code directory
Dalfampridine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-292_40bc3607-8ee1-5a56-e063-6294a90a3b3b
- Product NDC
- 16729-292
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Dalfampridine
- Labeler
- Accord Healthcare Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180918
- Source listing expiry
- 20261231
Source-listed ingredients
- DALFAMPRIDINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16729-292-12) · 16729-292-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →